Further $100k UCEED investment secured
Previous articleZymedyne registers new provisional patent application Next article Zymedyne published in prestigious Journal of experimental Medicine (JEM)
Zymedyne is excited to announce that the investment arm of the University of Calgary – UCEED, has invested a Further $100k and continues to show its support for our game changing technology by allowing us to continue to use the University of Calgary’s world class research facilities.
https://www.ucalgary.ca/uceed/about/portfolio/zymedyne
This important investment helps cover the cost of patent applications and helps generate additional funds by allowing us to utilize matching Canadian federal grant applications such as The National Research Council of Canada Industrial Research Assistance Program (NRC IRAP)
